![]() ![]() ![]()
EI Compendex Source List(2022年1月)
EI Compendex Source List(2020年1月)
EI Compendex Source List(2019年5月)
EI Compendex Source List(2018年9月)
EI Compendex Source List(2018年5月)
EI Compendex Source List(2018年1月)
中国科学引文数据库来源期刊列
CSSCI(2017-2018)及扩展期刊目录
2017年4月7日EI检索目录(最新)
2017年3月EI检索目录
最新公布北大中文核心期刊目录
SCI期刊(含影响因子)
![]() ![]() ![]()
论文范文
1. Introduction Cytokines and chemokines are key factors in the pathogenesis of influenza A virus (IAV) infection in human and animal models. Numerous studies of various IAV strains have revealed the involvement of various cytokines/chemokines in the pathology of this organism [1]. IAV infection causes various diseases in different organs, ranging from pneumonia [2–7] to encephalitis/encephalopathy [8–11]. To devise appropriate treatment strategies, the pathological events occurring at the primary loci of disease must be elucidated. Most reports describe studies that have used serum to investigate the cytokine/chemokine profiles of IAV-infected patients, especially pneumonia patients [2–7]. Nevertheless, it remains unclear whether these serum data correlate with the local immune response against IAV. This background has prompted us to characterize the inflammatory mediator response in serum compared with local samples, that is, bronchoalveolar lavage fluid (BALF) and cerebrospinal fluid (CSF) in IAV pneumonia and IAV encephalitis mouse models, respectively. This report presents evidence that interpreting a serum cytokine/chemokine profile in terms of a local immune response against IAV infection can be misleading. 2. Materials and Methods 2.1. Ethics The Animal Use Committee of the Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences approved this study (number OKU-2012628), which was conducted in accordance with the National Institutes of Health Guidelines. 2.2. Experimental Animals Eight-week-old male C57BL/6 mice were purchased from Charles River Laboratories Japan Inc. (Yokohama, Japan). The mice were housed in a specific pathogen-free animal facility at 25°C with a 12 hr light/dark cycle. They were fed a standard diet (Oriental MF; Oriental Yeast Co. Ltd., Tokyo, Japan). 2.3. Preparation of Viral Inocula Influenza A/WSN/33 (H1N1) virus was kindly provided by the Department of Microbiology, Kawasaki Medical University. This mouse-adapted H1N1 human IAV strain is not only pneumotropic after intranasal inoculation; it is also neurovirulent after inoculation into the CSF [12, 13]. We used this strain throughout this study. The virus was grown in 10-day-old embryonated chicken eggs. The virus titre was quantitated using a plaque assay with Madin-Darby canine kidney cells. ![]() |
|